You searched for metabolic diseases - Page 50 of 64

News and Trends 25 Nov 2024

Evotec on the brink of acquisition: At what cost for the biotech industry?

…pipeline spans over 200 co-owned assets, covering various therapeutic areas such as oncology, neurology, and metabolic diseases. Evotec also invests in early-stage biotech startups and academic spinouts, bridging the gap…

November 25, 2024 - 8 minutesmins - By Jules Adam

Startup Scout 30 Jun 2017

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and Zealand Pharma, Copenhagen is a hotspot for research on obesity and diabetes. This week we…

June 30, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 14 Jun 2017

French Hepatitis Cure is on Track with Positive Phase I Results

…gained attention in hepatobiliary and metabolic diseases, such as NASH, due to its favorable effect on liver regeneration and its ability to prevent liver fibrosis. On top of the positive…

June 14, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 30 Nov 2022

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

…novel therapies. TrialSpark is focused on clinical stage assets in rheumatology, dermatology, CNS, and cardiometabolic diseases, with a focus on chronic diseases that are treated outside of a hospital setting….

November 30, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 4 Aug 2017

Demo Day: Meet the Latest Generation of Synbio Startups from RebelBio

…and fuel their human trials at the same time. https://youtu.be/pBUJU3R8-T4?list=PLAMGx-_sKtpN2sRhWuyZ5zi5hQ0YnVMit Bonn Macy, from Phyteau Functionals, explains how his startup aims to tackle another of great health concerns: metabolic diseases, including…

August 4, 2017 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 25 Feb 2016

Boston Food Biotech Gets €38M from Nestlé

…to use as therapy for a range of metabolic diseases. The concept behind Pronutria’s food therapies: a specially created protein is prescribed as a nutraceutical to balance out the amino…

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

In Depth 3 Feb 2025

The biggest biotech funding rounds in January 2025

…metabolic disorders, autoimmune diseases, and hematology, which borught in $600 million, $450 million, and $225.5 million respectively, compared to just $140.65 million for oncology. Month-to-month comparison of biotech fundraising Below…

February 3, 2025 - 4 minutesmins - By Willow Shah-Neville

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

…cancer and glioblastoma (brain tumor). A recent study conducted at MD Anderson found that the loss of metabolic fitness in CAR-NK is a mechanism of resistance, eventually resulting in tumor…

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 7 Mar 2025

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

…these trials, oncology is the leading area of research and accounted for 32% of the trials in 2024. There was also significant growth last year in clinical trials on metabolic…

March 7, 2025 - 9 minutesmins - By Willow Shah-Neville

News and Trends 15 Jan 2021

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

…of conditions such as metabolic diseases and even hangovers. The skin, the largest organ of the body, has an expansive microbiome, which opens new possibilities for precision bioengineering. In spite…

January 15, 2021 - 4 minutesmins - By Kostas Vavitsas

News and Trends 3 Sep 2018

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

…central nervous system (CNS), as well as metabolic diseases. Led by the former CSO of Ablynx, a biotech that was acquired by Sanofi for €3.9Bn earlier this year, Evox…

September 3, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

multiple sclerosis neuron sheath medday Pharma

News and Trends 11 Mar 2020

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

…protective sheath. After this setback, MedDay will now talk to regulators and evaluate the trial data. “I remain confident of the importance of the neurometabolic approach to neurodegenerative diseases with…

March 11, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Evotec on the brink of acquisition: At what cost for the biotech industry?

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

French Hepatitis Cure is on Track with Positive Phase I Results

TrialSpark acquires immunodermatology portfolio and creates Libertas Bio

Demo Day: Meet the Latest Generation of Synbio Startups from RebelBio

Boston Food Biotech Gets €38M from Nestlé

The biggest biotech funding rounds in January 2025

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!